Skip to main content
HairCited

Treatment of female pattern hair loss with the androgen receptor antagonist flutamide.

Anosha Yazdabadi, Rod Sinclair
Case Report The Australasian journal of dermatology 2011 44 citations
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D21605098'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Type d'étude
Case Reports
Population
None
Intervention
Treatment of female pattern hair loss with the androgen receptor antagonist flutamide. None
Comparateur
None
Critère de jugement principal
hair loss
Direction de l'effet
Mixed
Risque de biais
High

Abstract

Female pattern hair loss is a common but difficult to manage condition. Commonly used treatments include oral antiandrogens such as spironolactone and topical minoxidil. The response to treatment is variable. We report a woman whose hair loss progressed while using spironolactone and topical minoxidil in combination, but reversed with flutamide, a potent androgen receptor antagonist.

En bref

A woman whose hair loss progressed while using spironolactone and topical minoxidil in combination, but reversed with flutamide, a potent androgen receptor antagonist is reported.

Used In Evidence Reviews

Similar Papers